chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 99.0
Sex: M
Vaccine: COVID19
Symptoms: Fall, Hypoxia, Positive airway pressure therapy, Respiratory failure, SARS-CoV-2 test positive
Clinical narrative: pt had a positive COVID test on 7/4/22 and was in the hospital with COVID pneumonia and respiratory failure after a fall; dc'd to SNF; 7/15/22 pt back to ED with increasing dyspnea; respiratory failure; placed on BiPAP; another positive COVID test; pt made slow improvement then became weaker with worsening hypoxia; family transitioned pt to comfort care and he passed away in the hospital
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Deafness, Ear discomfort, SARS-CoV-2 test positive, Sneezing
Clinical narrative: I tested positive for covid-19 on November 3, 2021 at I experienced sneezing, clogged ears, and hearing loss those are the only three symptoms that I experienced.
Age: 52.0
Sex: F
Vaccine: COVID19-2, COVID19-2
Symptoms: Anaemia, Blood test, Computerised tomogram head, Condition aggravated, Essential hypertension
Clinical narrative: Inflammation of spinal cord, unspecified cord compression, numbness and tingling of all limbs, primary hypertension, abnormal reflexes, and other symptoms and signs involving the musculoskeletal system, anemia, low B12 Vitamin levels- hospitalization at Hospital from 12/11/22-12/17/22 Received 5 days of Pretizone steroid, intramuscular injections of B-12 vitamins, recommended surgery to decompress spinal cord inflammation at neck.
Age: 52.0
Sex: F
Vaccine: COVID19-2, COVID19-2
Symptoms: Hypoaesthesia, Inflammation, Magnetic resonance imaging, Musculoskeletal disorder, Paraesthesia
Clinical narrative: Inflammation of spinal cord, unspecified cord compression, numbness and tingling of all limbs, primary hypertension, abnormal reflexes, and other symptoms and signs involving the musculoskeletal system, anemia, low B12 Vitamin levels- hospitalization at Hospital from 12/11/22-12/17/22 Received 5 days of Pretizone steroid, intramuscular injections of B-12 vitamins, recommended surgery to decompress spinal cord inflammation at neck.
Age: 52.0
Sex: F
Vaccine: COVID19-2, COVID19-2
Symptoms: Reflexes abnormal, Spinal cord compression, Vitamin B12 decreased
Clinical narrative: Inflammation of spinal cord, unspecified cord compression, numbness and tingling of all limbs, primary hypertension, abnormal reflexes, and other symptoms and signs involving the musculoskeletal system, anemia, low B12 Vitamin levels- hospitalization at Hospital from 12/11/22-12/17/22 Received 5 days of Pretizone steroid, intramuscular injections of B-12 vitamins, recommended surgery to decompress spinal cord inflammation at neck.
Age: 52.0
Sex: F
Vaccine: COVID19-2, COVID19-2
Symptoms: Computerised tomogram, Inflammation, Laboratory test, Magnetic resonance imaging, Muscle spasms
Clinical narrative: Inflammation of spinal cord, unspecified cord compression, numbness and tingling of all limbs, primary hypertension, abnormal reflexes, and other symptoms and signs involving the musculoskeletal system, anemia, low B12 Vitamin levels- hospitalization at Hospital from 12/11/22-12/17/22 Received 5 days of Pretizone steroid, intramuscular injections of B-12 vitamins, recommended surgery to decompress spinal cord inflammation at neck.
Age: 52.0
Sex: F
Vaccine: COVID19-2, COVID19-2
Symptoms: Muscular weakness, Paraesthesia, Paralysis, Sensory loss, Walking aid user
Clinical narrative: Inflammation of spinal cord, unspecified cord compression, numbness and tingling of all limbs, primary hypertension, abnormal reflexes, and other symptoms and signs involving the musculoskeletal system, anemia, low B12 Vitamin levels- hospitalization at Hospital from 12/11/22-12/17/22 Received 5 days of Pretizone steroid, intramuscular injections of B-12 vitamins, recommended surgery to decompress spinal cord inflammation at neck.
Age: 70.0
Sex: F
Vaccine: PPV
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Left arm swelling, redness, pain.
Age: 55.0
Sex: F
Vaccine: COVID19-2
Symptoms: Body temperature increased, COVID-19, Cough, Fatigue, Feeling abnormal
Clinical narrative: On Sunday 12/4/22 I had a runny nose and sore throat, my son called to say he had tested positive. On Monday I awoke with body aches, feeling bad, my throat was worse, so I took a home COVID-19 test, it came back positive. On Tuesday and Wednesday my symptoms stated progressively getting worse but once my temperature got up to 102.6F I called my doctor's office and was prescribed Paxlovid. I started taking it immediately I did start feeling better, it took two weeks to feel 90% better without fatigue. I do have a lingering cough.
Age: 55.0
Sex: F
Vaccine: COVID19-2
Symptoms: Malaise, Oropharyngeal pain, Pain, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: On Sunday 12/4/22 I had a runny nose and sore throat, my son called to say he had tested positive. On Monday I awoke with body aches, feeling bad, my throat was worse, so I took a home COVID-19 test, it came back positive. On Tuesday and Wednesday my symptoms stated progressively getting worse but once my temperature got up to 102.6F I called my doctor's office and was prescribed Paxlovid. I started taking it immediately I did start feeling better, it took two weeks to feel 90% better without fatigue. I do have a lingering cough.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Thrombocytopenia
Clinical narrative: Thrombocytopenia
Age: 66.0
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: Patient received second bivalent rx by mistake; no adverse effects noted
Age: 79.0
Sex: M
Vaccine: COVID19-2
Symptoms: COVID-19, Headache, Pyrexia, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: Tested Positive symptoms light headache runny nose and fever
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Exposure to SARS-CoV-2, Fatigue, Gastroenteritis viral, Headache
Clinical narrative: The Sunday before the rash developed I came down with the stomach flu and was throwing up all day. Then I stopped and it followed with a headache on Monday. Wednesday I woke up to an itchy neck that had a blistery rash on my shoulder, neck and clavicle area. The doctor put me in on antiviral and pain relief medication. The rash lasted for 2 weeks. Now I have residual itchy feeling in that area some time.  My husband wasn't feeling well a week ago and tested positive for COVID-19. This past Wednesday 12/14 I I took a test and it was positive. then the Sunday I started with symptoms of runny nose, sneezing, fatigue.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash, Rash vesicular, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: The Sunday before the rash developed I came down with the stomach flu and was throwing up all day. Then I stopped and it followed with a headache on Monday. Wednesday I woke up to an itchy neck that had a blistery rash on my shoulder, neck and clavicle area. The doctor put me in on antiviral and pain relief medication. The rash lasted for 2 weeks. Now I have residual itchy feeling in that area some time.  My husband wasn't feeling well a week ago and tested positive for COVID-19. This past Wednesday 12/14 I I took a test and it was positive. then the Sunday I started with symptoms of runny nose, sneezing, fatigue.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Sneezing, Vomiting
Clinical narrative: The Sunday before the rash developed I came down with the stomach flu and was throwing up all day. Then I stopped and it followed with a headache on Monday. Wednesday I woke up to an itchy neck that had a blistery rash on my shoulder, neck and clavicle area. The doctor put me in on antiviral and pain relief medication. The rash lasted for 2 weeks. Now I have residual itchy feeling in that area some time.  My husband wasn't feeling well a week ago and tested positive for COVID-19. This past Wednesday 12/14 I I took a test and it was positive. then the Sunday I started with symptoms of runny nose, sneezing, fatigue.
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Headache, Lethargy, Night sweats
Clinical narrative: On Monday after a camping trip, I was feeling lethargic.  I took some ibuprofen because I was also very sore.  I took a nap in the middle of the day.  I spoke with my doctor on Wednesday.  Tuesday, September 6, 2022,  I felt better but developed a sore throat and a bit of a cough.  My headache and body aches went away.  Tuesday night I tested positive for COVID-19.  I was prescribed Paxlovid.  I did not test negative for about 2 weeks.  Thursday night I had a mild sore throat and felt like I had a night fever/night sweat.  My sore throat diminished over time as well as my headache.  I never felt out of breath or lethargic around the house.
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Pain, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: On Monday after a camping trip, I was feeling lethargic.  I took some ibuprofen because I was also very sore.  I took a nap in the middle of the day.  I spoke with my doctor on Wednesday.  Tuesday, September 6, 2022,  I felt better but developed a sore throat and a bit of a cough.  My headache and body aches went away.  Tuesday night I tested positive for COVID-19.  I was prescribed Paxlovid.  I did not test negative for about 2 weeks.  Thursday night I had a mild sore throat and felt like I had a night fever/night sweat.  My sore throat diminished over time as well as my headache.  I never felt out of breath or lethargic around the house.
Age: 53.0
Sex: F
Vaccine: COVID19-2
Symptoms: Unevaluable event
Clinical narrative: None stated.
Age: 71.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, Cough, Diarrhoea, Fatigue, Malaise
Clinical narrative: I received my 5th dose of Pfizer Bivalent on 09/19/2022. My adverse event of COVID-19 Infection started on 12/06/2022 in the morning. I had a sore throat ,cough and fatigue.  I also had diarrhea for 1 day. I did a home COVID-19 test which was positive. The next day on 12/07/2022 I contacted my doctor. They prescribed me cough syrup and Mucinex. I had mild COVID-19 symptoms.
Age: 71.0
Sex: F
Vaccine: COVID19-2
Symptoms: Oropharyngeal pain, SARS-CoV-2 test positive
Clinical narrative: I received my 5th dose of Pfizer Bivalent on 09/19/2022. My adverse event of COVID-19 Infection started on 12/06/2022 in the morning. I had a sore throat ,cough and fatigue.  I also had diarrhea for 1 day. I did a home COVID-19 test which was positive. The next day on 12/07/2022 I contacted my doctor. They prescribed me cough syrup and Mucinex. I had mild COVID-19 symptoms.
Age: 79.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Balance disorder, Bed rest, Loss of personal independence in daily activities, Mobility decreased
Clinical narrative: BOOSTER #1 Pfizer 6FS6317 Received injection 10/30/21 in the morning at local grocery store pharmacy. Normal ADLs. Normal bedtime. Got up in middle of night to use bathroom (10/31/21). Legs collapsed in bathroom. Experienced muscle weakness. Could not get up independently or with assistance. Husband pulled her on a sheet into bedroom. Was still unable to get off floor. Called 911-ambulance. Transported to Hospital, and admitted for three days. Felt better about 24-hours after admission. At discharge, she was prescribed antibiotic and told probable cause of collapse was urinary tract infection.  BOOSTER #2 Pfizer FK9895 Received injection (04/11/22) in the morning at local grocery store pharmacy. Normal ADLs. Normal bedtime. Got up in the middle of the night to use the bathroom (04/12/22). Legs collapsed in hallway. Experienced muscle weakness. Could not get up independently or with assistance. Neuromuscular weakness more severe. Husband provided pillow, blanket, and diaper (not used prior to event)? Patient stayed on floor until the next day when she was able to roll to hands and knees and crawl to bedroom. Did not go to hospital/seek medical attention due to cost/expense of prior hospitalization. Bed rested the following day. Was able to walk downstairs/eat dinner that evening.  Patient has not experienced this type of event outside of the two episodes after booster vaccinations. Both events occurred within 24-hours after booster vaccinations. Both episode symptoms improved about 12-24 hours after collapse. Patient was able to return to ADLs 24 to 36 hours after event onset. Return to baseline about 48-72 days after episode.  - Patient is concerned about receiving additional COVID vaccinations.  - Patient is concerned about increased severity of second event.  - Patient is concerned about cost of medical treatment with event.    - Patient discussed events with primary care physician at annual checkup. Patient felt physician disregarded her concerns. She was told to get the next booster. She is afraid to do so.  - Patient does not believe either event was reported to VAERS by hospital or primary care physician. - Continued mild neuromuscular deficit (strength and balance)  and neuropathy in feet and toes. Unknown if related to episodes or other ongoing health conditions (type 2 diabetes mellitus, age?)
Age: 79.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Muscular weakness, Musculoskeletal disorder, Neuropathy peripheral, Syncope, Urinary tract infection
Clinical narrative: BOOSTER #1 Pfizer 6FS6317 Received injection 10/30/21 in the morning at local grocery store pharmacy. Normal ADLs. Normal bedtime. Got up in middle of night to use bathroom (10/31/21). Legs collapsed in bathroom. Experienced muscle weakness. Could not get up independently or with assistance. Husband pulled her on a sheet into bedroom. Was still unable to get off floor. Called 911-ambulance. Transported to Hospital, and admitted for three days. Felt better about 24-hours after admission. At discharge, she was prescribed antibiotic and told probable cause of collapse was urinary tract infection.  BOOSTER #2 Pfizer FK9895 Received injection (04/11/22) in the morning at local grocery store pharmacy. Normal ADLs. Normal bedtime. Got up in the middle of the night to use the bathroom (04/12/22). Legs collapsed in hallway. Experienced muscle weakness. Could not get up independently or with assistance. Neuromuscular weakness more severe. Husband provided pillow, blanket, and diaper (not used prior to event)? Patient stayed on floor until the next day when she was able to roll to hands and knees and crawl to bedroom. Did not go to hospital/seek medical attention due to cost/expense of prior hospitalization. Bed rested the following day. Was able to walk downstairs/eat dinner that evening.  Patient has not experienced this type of event outside of the two episodes after booster vaccinations. Both events occurred within 24-hours after booster vaccinations. Both episode symptoms improved about 12-24 hours after collapse. Patient was able to return to ADLs 24 to 36 hours after event onset. Return to baseline about 48-72 days after episode.  - Patient is concerned about receiving additional COVID vaccinations.  - Patient is concerned about increased severity of second event.  - Patient is concerned about cost of medical treatment with event.    - Patient discussed events with primary care physician at annual checkup. Patient felt physician disregarded her concerns. She was told to get the next booster. She is afraid to do so.  - Patient does not believe either event was reported to VAERS by hospital or primary care physician. - Continued mild neuromuscular deficit (strength and balance)  and neuropathy in feet and toes. Unknown if related to episodes or other ongoing health conditions (type 2 diabetes mellitus, age?)
Age: 70.0
Sex: M
Vaccine: COVID19-2, UNK
Symptoms: Back pain, Blood test, Chest X-ray, Pain, X-ray
Clinical narrative: After receiving the vaccine, I had a short pain in my back anytime I moved to the point I was doubled over. It felt like something stabbing my lungs. I went to the doctor who took some x-rays, prescribed Flexeril and gave me an injection with 2 medications in it. I was prescribed a steroid to help with the symptoms as well. The medication did help with the symptoms but since I finished the Flexeril last week, I am starting to get the stabbing pain back. It's not as bad as before but it is returning. I do not feel that I have recovered as I still get that twitch.
Age: 42.0
Sex: M
Vaccine: COVID19-2
Symptoms: No adverse event, Underdose
Clinical narrative: Patient who is an adult was given 0.25mL of the Moderna Bivalent COVID booster vaccine, which is less than the authorized dose of 0.50mL.  No adverse events were noted at the time of the administration.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Anticoagulant therapy, COVID-19, Death, SARS-CoV-2 test positive
Clinical narrative: MODERNA COVID VACCINE DOSE 3 GIVEN 12/1/21, LOT #076C21A; pt had a positive COVID test on 7/3/22; O2 via NC; isolation unit; given Mucinex, Zinc, Vitamin D, Eliquis; 7/5/22 family changed pt's status to DNR with comfort measures; pt passed away in nursing home
Age: 65.0
Sex: M
Vaccine: COVID19-2
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Contracted confirmed COVID-19 infection some 11 weeks later.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Patient received dose of COVID19 (Pfizer-BioNTech) past the vial BUD (Beyond Use Date) of 32 days from transfer of deep freeze to refrigeration temperature. BUD date of dose was 1/7/22 at 0900, patient received vaccination on 1/14/22 at approximately 10:30am. When error discovered facility contacted CDC for course of action. At direction of the CDC, patient contacted regarding occurrence to offer re-vaccination of dose. Patient declined revaccination. No adverse side effects or event as result of dose.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Patient received dose of COVID19 (Pfizer-BioNTech) past the vial BUD (Beyond Use Date) of 32 days from transfer of deep freeze to refrigeration temperature. BUD date of dose was 1/7/22 at 0900, patient received vaccination on 1/14/22 at approximately 9:30. When error discovered facility contacted CDC for course of action. At direction of the CDC, patient contacted regarding occurrence to offer re-vaccination of dose. Patient accepted revaccination dose on 2/7/2022. No adverse side effects or event as result of dose reported.
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Blood glucose, Gaze palsy, Hyperhidrosis, Malaise, Muscle rigidity
Clinical narrative: patient stated before vaccine she was nervous and might cry. (patient was visibly shaking and stated when she was younger she had a bad experience so that is why she was nervous.) Once vaccine was given pt asked if that was all because it didn't hurt and didn't cry. Approx 2 minutes later she alerted that she wasn't feeling so well and thought she may vomit. A bucket was then retrieved and 1 moment later patient had fainted/ experienced a seizure. Patients body went rigid (legs, arms, neck) and at head was turned downward and to the right. Her eyes were dilated and she was staring straight ahead. Approx 45 seconds went by before patient started to come around. She stated she could hear me when this was occurring however she was extremely pale, and because very sweaty. Her blood pressure was then taken and 1st reading was 56/37 at 1:35pm. EMS was called as soon as she fainted and was on the scene within 5 minutes. Paramedics then took over and performed another BP check which was then 88/61 at 1:45pm. EMS evaluated her, called her mother and stayed with the patient until she was released to her brother and walked out of the pharmacy on her own.
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Mydriasis, Nausea, Pallor, Seizure, Syncope
Clinical narrative: patient stated before vaccine she was nervous and might cry. (patient was visibly shaking and stated when she was younger she had a bad experience so that is why she was nervous.) Once vaccine was given pt asked if that was all because it didn't hurt and didn't cry. Approx 2 minutes later she alerted that she wasn't feeling so well and thought she may vomit. A bucket was then retrieved and 1 moment later patient had fainted/ experienced a seizure. Patients body went rigid (legs, arms, neck) and at head was turned downward and to the right. Her eyes were dilated and she was staring straight ahead. Approx 45 seconds went by before patient started to come around. She stated she could hear me when this was occurring however she was extremely pale, and because very sweaty. Her blood pressure was then taken and 1st reading was 56/37 at 1:35pm. EMS was called as soon as she fainted and was on the scene within 5 minutes. Paramedics then took over and performed another BP check which was then 88/61 at 1:45pm. EMS evaluated her, called her mother and stayed with the patient until she was released to her brother and walked out of the pharmacy on her own.
Age: 73.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Patient received dose of COVID19 (Pfizer-BioNTech) past the vial BUD (Beyond Use Date) of 32 days from transfer of deep freeze to refrigeration temperature. BUD date of dose was 1/7/22 at 0900, patient received vaccination on 1/7/22 at approximately 10:50am. When error discovered facility contacted CDC for course of action. At direction of the CDC, patient contacted regarding occurrence to offer re-vaccination of dose. Patient accepted revaccination on 1/28/22. No adverse side effects or event as result of dose.
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Patient received dose of COVID19 (Pfizer-BioNTech) past the vial BUD (Beyond Use Date) of 32 days from transfer of deep freeze to refrigeration temperature. BUD date of dose was 1/7/22 at 0900, patient received vaccination on 1/14/22 at approximately 11:10. When error discovered facility contacted CDC for course of action. At direction of the CDC, patient contacted regarding occurrence to offer re-vaccination of dose. Patient did not respond to attempts to contact. No adverse side effects or event as result of dose reported.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Patient received dose of COVID19 (Pfizer-BioNTech) past the vial BUD (Beyond Use Date) of 32 days from transfer of deep freeze to refrigeration temperature. BUD date of dose was 1/7/22 at 0900, patient received vaccination on 1/07/22 at approximately 10:10am. When error discovered facility contacted CDC for course of action. At direction of the CDC, patient contacted regarding occurrence to offer re-vaccination of dose. Patient did not respond to attempts to contact. No adverse side effects or event as result of dose reported.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Patient received dose of COVID19 (Pfizer-BioNTech) past the vial BUD (Beyond Use Date) of 32 days from transfer of deep freeze to refrigeration temperature. BUD date of dose was 1/7/22 at 0900, patient received vaccination on 1/14/22. When error discovered facility contacted CDC for course of action. At direction of the CDC, patient outreached regarding occurrence to offer re-vaccination of dose. No adverse side effects or event as result of dose.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Patient received dose of COVID19 (Pfizer-BioNTech) past the vial BUD (Beyond Use Date) of 32 days from transfer of deep freeze to refrigeration temperature. BUD date of dose was 1/7/22 at 0900, patient received vaccination on 1/14/22 at approximately 10:30am. When error discovered facility contacted CDC for course of action. At direction of the CDC, patient contacted regarding occurrence to offer re-vaccination of dose. Patient accepted revaccination on 4/27/2022. No adverse side effects or event as result of dose.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Patient received dose of COVID19 (Pfizer-BioNTech) past the vial BUD (Beyond Use Date) of 32 days from transfer of deep freeze to refrigeration temperature. BUD date of dose was 1/7/22 at 0900, patient received vaccination on 1/14/22 at approximately 09:10am. When error discovered facility contacted CDC for course of action. At direction of the CDC, patient contacted regarding occurrence to offer re-vaccination of dose. Patient accepted revaccination on 1/31/2022. No adverse side effects or event as result of dose.
Age: 63.0
Sex: F
Vaccine: FLU4
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: No adverse event. Patient under age 65 but received HD fluzone.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Patient received dose of COVID19 (Pfizer-BioNTech) past the vial BUD (Beyond Use Date) of 32 days from transfer of deep freeze to refrigeration temperature. BUD date of dose was 1/7/22 at 0900, patient received vaccination on 1/14/22 at approximately 10:30am. When error discovered facility contacted CDC for course of action. At direction of the CDC, patient contacted regarding occurrence to offer re-vaccination of dose. Patient accepted revaccination on 1/24/2022. No adverse side effects or event as result of dose.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Patient received dose of COVID19 (Pfizer-BioNTech) past the vial BUD (Beyond Use Date) of 32 days from transfer of deep freeze to refrigeration temperature. BUD date of dose was 1/7/22 at 0900, patient received vaccination on 1/14/22 at approximately 08:10am. When error discovered facility contacted for course of action. At direction of the, patient contacted regarding occurrence to offer re-vaccination of dose. Patient accepted revaccination on 1/27/2022. No adverse side effects or event as result of dose.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Patient received dose of COVID19 (Pfizer-BioNTech) past the vial BUD (Beyond Use Date) of 32 days from transfer of deep freeze to refrigeration temperature. BUD date of dose was 1/7/22 at 0900, patient received vaccination on 1/07/22 at approximately 09:30am. When error discovered facility contacted for course of action. At direction of the, patient contacted regarding occurrence to offer re-vaccination of dose. Patient accepted revaccination on 1/28/2022. No adverse side effects or event as result of dose.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Patient received dose of COVID19 (Pfizer-BioNTech) past the vial BUD (Beyond Use Date) of 32 days from transfer of deep freeze to refrigeration temperature. BUD date of dose was 1/7/22 at 0900, patient received vaccination on 1/14/22 at approximately 08:30am. When error discovered facility contacted for course of action. At direction of the, patient contacted regarding occurrence to offer re-vaccination of dose. Patient declined revaccination. No adverse side effects or event as result of dose reported.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Patient received dose of COVID19 (Pfizer-BioNTech) past the vial BUD (Beyond Use Date) of 32 days from transfer of deep freeze to refrigeration temperature. BUD date of dose was 1/7/22 at 0900, patient received vaccination on 1/7/22 at approximately 11:10am. When error discovered facility contacted for course of action. At direction of the, patient contacted regarding occurrence to offer re-vaccination of dose. Patient declined revaccination. No adverse side effects or event as result of dose reported.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Patient received dose of COVID19 (Pfizer-BioNTech) past the vial BUD (Beyond Use Date) of 32 days from transfer of deep freeze to refrigeration temperature. BUD date of dose was 1/7/22 at 0900, patient received vaccination on 1/14/22 at approximately 09:10am. When error discovered facility contacted for course of action. At direction of the facility, patient contacted regarding occurrence to offer re-vaccination of dose. Patient accepted revaccination on 1/27/2022. No adverse side effects or event as result of dose.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Alopecia
Clinical narrative: I was brushing my hair in the shower and clumps of hair was coming out. My hair is also thinning. I talked to my doctor, and she said it might be a symptom of COVID-19. I have never had COVID-19. I have an appointment for blood work.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Patient received dose of COVID19 (Pfizer-BioNTech) past the vial BUD (Beyond Use Date) of 32 days from transfer of deep freeze to refrigeration temperature. BUD date of dose was 1/7/22 at 0900, patient received vaccination on 1/7/22 at approximately 10:50am. When error discovered facility contacted for course of action. At direction of the, patient contacted regarding occurrence to offer re-vaccination of dose. Patient declined revaccination. No adverse side effects or event as result of dose reported.
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Patient received dose of COVID19 (Pfizer-BioNTech) past the vial BUD (Beyond Use Date) of 32 days from transfer of deep freeze to refrigeration temperature. BUD date of dose was 1/7/22 at 0900, patient received vaccination on 1/14/22 at approximately 09:30am. When error discovered facility contacted CDC for course of action. At direction of the CDC, patient contacted regarding occurrence to offer re-vaccination of dose. Patient declined revaccination. No adverse side effects or event as result of dose reported.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Patient received dose of COVID19 (Pfizer-BioNTech) past the vial BUD (Beyond Use Date) of 32 days from transfer of deep freeze to refrigeration temperature. BUD date of dose was 1/7/22 at 0900, patient received vaccination on 1/7/22 at approximately 08:50am. When error discovered facility contacted CDC for course of action. At direction of the CDC, patient contacted regarding occurrence to offer re-vaccination of dose. Patient declined revaccination. No adverse side effects or event as result of dose reported.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Patient received dose of COVID19 (Pfizer-BioNTech) past the vial BUD (Beyond Use Date) of 32 days from transfer of deep freeze to refrigeration temperature. BUD date of dose was 1/7/22 at 0900, patient received vaccination on 1/7/22 at approximately 08:50am. When error discovered facility contacted for course of action. At direction of the, patient contacted regarding occurrence to offer re-vaccination of dose. Patient accepted revaccination on 1/27/2022. No adverse side effects or event as result of dose.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Patient received dose of COVID19 (Pfizer-BioNTech) past the vial BUD (Beyond Use Date) of 32 days from transfer of deep freeze to refrigeration temperature. BUD date of dose was 1/7/22 at 0900, patient received vaccination on 1/14/22 at approximately 08:50am. When error discovered facility contacted CDC for course of action. At direction of the CDC, patient contacted regarding occurrence to offer re-vaccination of dose. Patient accepted revaccination on 1/31/2022. No adverse side effects or event as result of dose.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Patient received dose of COVID19 (Pfizer-BioNTech) past the vial BUD (Beyond Use Date) of 32 days from transfer of deep freeze to refrigeration temperature. BUD date of dose was 1/7/22 at 0900, patient received vaccination on 1/7/22 at approximately 9:10am. When error discovered facility contacted CDC for course of action. At direction of the CDC, patient contacted regarding occurrence to offer re-vaccination of dose. Patient did not respond to attempts to contact. No adverse side effects or event as result of dose reported.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Patient received dose of COVID19 (Pfizer-BioNTech) past the vial BUD (Beyond Use Date) of 32 days from transfer of deep freeze to refrigeration temperature. BUD date of dose was 1/7/22 at 0900, patient received vaccination on 1/7/22 at approximately 10:30am. When error discovered facility contacted CDC for course of action. At direction of the CDC, patient contacted regarding occurrence to offer re-vaccination of dose. Patient accepted revaccination on 2/21/2022. No adverse side effects or event as result of dose.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Patient received dose of COVID19 (Pfizer-BioNTech) past the vial BUD (Beyond Use Date) of 32 days from transfer of deep freeze to refrigeration temperature. BUD date of dose was 1/7/22 at 0900, patient received vaccination on 1/7/22 at approximately 10:10am. When error discovered facility contacted for course of action. At direction of the, patient contacted regarding occurrence to offer re-vaccination of dose. Patient declined revaccination. No adverse side effects or event as result of dose reported.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Patient received dose of COVID19 (Pfizer-BioNTech) past the vial BUD (Beyond Use Date) of 32 days from transfer of deep freeze to refrigeration temperature. BUD date of dose was 1/7/22 at 0900, patient received vaccination on 1/14/22 at approximately 08:30am. When error discovered facility contacted CDC for course of action. At direction of the CDC, patient contacted regarding occurrence to offer re-vaccination of dose. Patient accepted revaccination on 2/4/2022. No adverse side effects or event as result of dose.
Age: 62.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, Chills, Condition aggravated, Cough, Headache
Clinical narrative: 12/11/2022 late in the evening I experienced a headache and sore throat.  Tested with a PCR COVID-19 test through public health.  Test results Positive.  These got worse into 12/12 where they were joined by chills, cough and congestion.  Telehealth with Doctor.  Prescribed Paxlovid.  Symptoms gradually got better over the next 2 days until 12/14.  Slight cough and some congestion lingered.
Age: 62.0
Sex: F
Vaccine: COVID19-2
Symptoms: Oropharyngeal pain, Respiratory tract congestion, SARS-CoV-2 test positive
Clinical narrative: 12/11/2022 late in the evening I experienced a headache and sore throat.  Tested with a PCR COVID-19 test through public health.  Test results Positive.  These got worse into 12/12 where they were joined by chills, cough and congestion.  Telehealth with Doctor.  Prescribed Paxlovid.  Symptoms gradually got better over the next 2 days until 12/14.  Slight cough and some congestion lingered.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Patient received dose of COVID19 (Pfizer-BioNTech) past the vial BUD (Beyond Use Date) of 32 days from transfer of deep freeze to refrigeration temperature. BUD date of dose was 1/7/22 at 0900, patient received vaccination on 1/7/22 at approximately 10:10am. When error discovered facility contacted CDC for course of action. At direction of the CDC, patient contacted regarding occurrence to offer re-vaccination of dose. Patient declined revaccination. No adverse side effects or event as result of dose reported.
Age: 89.0
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered
Clinical narrative: Client called program requesting COVID vaccine dose.  Review of Client record indicated one dose of Moderna previously given,  client unable to identify which dose he was needing.  Upon arrival and review of client vaccine card he had completed a primary series already so appeared eligible for a bivalent booster dose. Dose given after completion of screening. At that time a second vaccine card was produced showing that client had received bivalent booster on 9-22-2022.  Situation was explained to client, 15 minute wait was completed, client has no change in condition noted, no untoward effects noted and had been provided an EUA prior to the dose with a verbal explanation of possible expected side effects from receiving the vaccine.
Age: 25.0
Sex: F
Vaccine: TDAP
Symptoms: Exposure during pregnancy, Extra dose administered
Clinical narrative: Was given another dose of Tdap on 12/15/2022 and had already received on 12/09/2022. Current pregnancy EDD is 01/05/2023.
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Patient received dose of COVID19 (Pfizer-BioNTech) past the vial BUD (Beyond Use Date) of 32 days from transfer of deep freeze to refrigeration temperature. BUD date of dose was 1/7/22 at 0900, patient received vaccination on 1/7/22. When error discovered facility contacted CDC for course of action. At direction of the CDC, patient contacted regarding occurrence to offer re-vaccination of dose. Patient accepted revaccination on 1/28/2022. No adverse side effects or event as result of dose.
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Patient received dose of COVID19 (Pfizer-BioNTech) past the vial BUD (Beyond Use Date) of 32 days from transfer of deep freeze to refrigeration temperature. BUD date of dose was 1/7/22 at 0900, patient received vaccination on 1/14/22. When error discovered facility contacted CDC for course of action. At direction of the CDC, patient contacted regarding occurrence to offer re-vaccination of dose. No adverse side effects or event as result of dose.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Patient received dose of COVID19 (Pfizer-BioNTech) past the vial BUD (Beyond Use Date) of 32 days from transfer of deep freeze to refrigeration temperature. BUD date of dose was 1/7/22 at 0900, patient received vaccination on 1/14/22. When error discovered facility contacted CDC for course of action. At direction of the CDC, patient contacted regarding occurrence to offer re-vaccination of dose. No adverse side effects or event as result of dose.
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Patient received dose of COVID19 (Pfizer-BioNTech) past the vial BUD (Beyond Use Date) of 32 days from transfer of deep freeze to refrigeration temperature. BUD date of dose was 1/7/22 at 0900, patient received vaccination on 1/14/22. When error discovered facility contacted CDC for course of action. At direction of the CDC, patient outreached regarding occurrence to offer re-vaccination of dose. No adverse side effects or event as result of dose.
Age: 59.0
Sex: F
Vaccine: COVID19-2
Symptoms: No adverse event, Underdose
Clinical narrative: Patient who is an adult was given 0.25mL of the Moderna Bivalent COVID booster vaccine, which is less than the authorized dose of 0.50mL.  No adverse events were noted at the time of the administration.
Age: 68.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, Condition aggravated, Cough, Exposure to SARS-CoV-2, Fatigue
Clinical narrative: I received the Moderna Bivalent booster for COVID-19 on 11/4/2022. On 12/5/2022, I had a tickle in my throat. I took a lozenge, and it went away. I also had some scratchiness on the side of my throat. I have GERD, so I assumed that it was caused by that. On 12/6/2022, I took a home antigen test upon waking up, because I had just visited a heavily populated area. The result was positive, to my surprise. I self-isolated for 10 days. I called my doctor, and I was prescribed Paxlovid and promethazine DM. He instructed me to wait until 12/8/2022 to begin taking the Paxlovid. He told me that if I didn't feel better by then, I could go ahead and start taking it. I didn't feel very bad, but I decided to start taking it anyway on 12/8/2022, and I finished it 12/12/2022. On 12/12/2022, I tested negative for the first time since getting sick. I stayed in isolation until 12/16/2022. I tested myself daily, and the results were negative from 12/12/2022 until 12/18/2022. However, I tested positive again on 12/19/2022. I called my doctor, who asked me to come to the practice. When I got there, I was tested for COVID-19 and the flu. The results of the clinical tests for both COVID-19 and the flu were negative. My blood pressure, my oxygen, and my temperature were all good. The only symptoms of COVID-19 that I had were fatigue and an occasional slight cough. The fatigue got worse on the afternoon 12/19/2022. I also developed a headache and nasal congestion. I continue to have these symptoms at the time of this writing, and when I tested myself again this morning, the result was still positive.
Age: 68.0
Sex: F
Vaccine: COVID19-2
Symptoms: Gastrooesophageal reflux disease, Headache, Influenza virus test negative, Nasal congestion, Oropharyngeal discomfort
Clinical narrative: I received the Moderna Bivalent booster for COVID-19 on 11/4/2022. On 12/5/2022, I had a tickle in my throat. I took a lozenge, and it went away. I also had some scratchiness on the side of my throat. I have GERD, so I assumed that it was caused by that. On 12/6/2022, I took a home antigen test upon waking up, because I had just visited a heavily populated area. The result was positive, to my surprise. I self-isolated for 10 days. I called my doctor, and I was prescribed Paxlovid and promethazine DM. He instructed me to wait until 12/8/2022 to begin taking the Paxlovid. He told me that if I didn't feel better by then, I could go ahead and start taking it. I didn't feel very bad, but I decided to start taking it anyway on 12/8/2022, and I finished it 12/12/2022. On 12/12/2022, I tested negative for the first time since getting sick. I stayed in isolation until 12/16/2022. I tested myself daily, and the results were negative from 12/12/2022 until 12/18/2022. However, I tested positive again on 12/19/2022. I called my doctor, who asked me to come to the practice. When I got there, I was tested for COVID-19 and the flu. The results of the clinical tests for both COVID-19 and the flu were negative. My blood pressure, my oxygen, and my temperature were all good. The only symptoms of COVID-19 that I had were fatigue and an occasional slight cough. The fatigue got worse on the afternoon 12/19/2022. I also developed a headache and nasal congestion. I continue to have these symptoms at the time of this writing, and when I tested myself again this morning, the result was still positive.
Age: 68.0
Sex: F
Vaccine: COVID19-2
Symptoms: SARS-CoV-2 test positive, Throat irritation
Clinical narrative: I received the Moderna Bivalent booster for COVID-19 on 11/4/2022. On 12/5/2022, I had a tickle in my throat. I took a lozenge, and it went away. I also had some scratchiness on the side of my throat. I have GERD, so I assumed that it was caused by that. On 12/6/2022, I took a home antigen test upon waking up, because I had just visited a heavily populated area. The result was positive, to my surprise. I self-isolated for 10 days. I called my doctor, and I was prescribed Paxlovid and promethazine DM. He instructed me to wait until 12/8/2022 to begin taking the Paxlovid. He told me that if I didn't feel better by then, I could go ahead and start taking it. I didn't feel very bad, but I decided to start taking it anyway on 12/8/2022, and I finished it 12/12/2022. On 12/12/2022, I tested negative for the first time since getting sick. I stayed in isolation until 12/16/2022. I tested myself daily, and the results were negative from 12/12/2022 until 12/18/2022. However, I tested positive again on 12/19/2022. I called my doctor, who asked me to come to the practice. When I got there, I was tested for COVID-19 and the flu. The results of the clinical tests for both COVID-19 and the flu were negative. My blood pressure, my oxygen, and my temperature were all good. The only symptoms of COVID-19 that I had were fatigue and an occasional slight cough. The fatigue got worse on the afternoon 12/19/2022. I also developed a headache and nasal congestion. I continue to have these symptoms at the time of this writing, and when I tested myself again this morning, the result was still positive.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Patient received dose of COVID19 (Pfizer-BioNTech) past the vial BUD (Beyond Use Date) of 32 days from transfer of deep freeze to refrigeration temperature. BUD date of dose was 1/7/22 at 0900, patient received vaccination on 1/14/22. When error discovered facility contacted CDC for course of action. At direction of the CDC, patient outreached regarding occurrence to offer re-vaccination of dose. No adverse side effects or event as result of dose.
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Patient received dose of COVID19 (Pfizer-BioNTech) past the vial BUD (Beyond Use Date) of 32 days from transfer of deep freeze to refrigeration temperature. BUD date of dose was 1/7/22 at 0900, patient received vaccination on 1/07/22. When error discovered facility contacted CDC for course of action. At direction of the CDC, patient outreached regarding occurrence to offer re-vaccination of dose. No adverse side effects or event as result of dose.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Patient received dose of COVID19 (Pfizer-BioNTech) past the vial BUD (Beyond Use Date) of 32 days from transfer of deep freeze to refrigeration temperature. BUD date of dose was 1/7/22 at 0900, patient received vaccination on 1/14/22. When error discovered facility contacted CDC for course of action. At direction of the CDC, patient outreached regarding occurrence to offer re-vaccination of dose. No adverse side effects or event as result of dose.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Patient received dose of COVID19 (Pfizer-BioNTech) past the vial BUD (Beyond Use Date) of 32 days from transfer of deep freeze to refrigeration temperature. BUD date of dose was 1/7/22 at 0900, patient received vaccination on 1/14/22. When error discovered facility contacted CDC for course of action. At direction of the CDC, patient outreached regarding occurrence to offer re-vaccination of dose. No adverse side effects or event as result of dose.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Patient received dose of COVID19 (Pfizer-BioNTech) past the vial BUD (Beyond Use Date) of 32 days from transfer of deep freeze to refrigeration temperature. BUD date of dose was 1/7/22 at 0900, patient received vaccination on 1/14/22. When error discovered facility contacted CDC for course of action. At direction of the CDC, patient outreached regarding occurrence to offer re-vaccination of dose. No adverse side effects or event as result of dose.
Age: 51.0
Sex: F
Vaccine: COVID19-2
Symptoms: Blood glucose abnormal, Heavy menstrual bleeding, Postmenopausal haemorrhage, Thrombosis
Clinical narrative: Two months after vaccine developed a blood clot on finger inside the inside of palm; Went to Urgent Care, they sent me to the ER; Blood sugar was tested; Doctor only visually examined my finger; Was told to keep watch on it and it did go away on its own like Doctor said it should; Was in Menopause for 2 years, then suddenly got a very heavy period;